Providing leadership for the life sciences industry

Placement | Dr Peter Simpson joins The Medicines Discovery Catapult as CSO

Posted on 06/06/2017

The Medicines Discovery Catapult has appointed Dr Peter Simpson as Chief Scientific Officer, following a successful executive search conducted by The RSA Group.

Dr Andy Theodorou of The RSA Group commented “We are delighted to have been able to support and advise The Medicines Discovery Catapult in this key addition to their senior management team.  We extend our best wishes to Dr Simpson as he leads scientific strategy and collaborative projects at the MDC.”

Read the full release here: https://md.catapult.org.uk/news/medicines-discovery-catapult-makes-four-senior-hires-management-team/

How the RSA group helps global Life Sciences find the best Life Sciences talent

Why choose RSA?

How the RSA group helps global life sciences find the best talent.